The Standard Model (SM) predicts the distribution of emission angles for the beta particle and neutrino, and any observed difference would reveal new aspects of the weak nuclear force.

While beta-particle emitters like 177 Lu-DOTATATE (Lutathera) have become standard as highly effective and well-tolerated therapy, their limitations---namely relapse within a few years---have ...

For normal double-beta decay, the half life — the time it takes for half the substance to decay — is 10 21 years, or 100 billion times longer than the age of the universe.

A review in Brain Medicine unveils the potential of targeted alpha particle therapy (TAT) as an innovative and exciting breakthrough for neuroendocrine tumours (NETs). Unlike traditional beta ...